Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma × sargramostim × Clear all

Sponsor

Conditions

Leukemia 22 Lymphoma 14 Leukemia, Myeloid, Acute 14 Myelodysplastic Syndromes 12 Leukemia, Lymphocytic, Chronic, B-Cell 12 Breast Neoplasms 11 Prostatic Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Multiple Myeloma 9 Melanoma 9 Lymphoma, Follicular 9 Neuroblastoma 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Ovarian Neoplasms 7 Congenital Abnormalities 7 Lymphoma, Non-Hodgkin 6 Hodgkin Disease 5 Neoplasms, Plasma Cell 4 Neoplasm Metastasis 4 Myeloproliferative Disorders 4 Lymphoma, Mantle-Cell 4 Leukemia, Myeloid, Chronic-Phase 4 Glioblastoma 4 Fallopian Tube Neoplasms 4 Anemia, Refractory, with Excess of Blasts 4 Waldenstrom Macroglobulinemia 3 Osteosarcoma 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, B-Cell, Marginal Zone 3

Interventions

Carboplatin 23 Cisplatin 19 pembrolizumab 13 Paclitaxel 12 Gemcitabine 12 Pemetrexed 11 130-nm albumin-bound paclitaxel 9 Everolimus 8 Cetuximab 8 Fluorouracil 7 Axitinib 6 osimertinib 5 durvalumab 5 Sunitinib 5 Radiotherapy 5 Erlotinib Hydrochloride 5 Docetaxel 5 Cyclophosphamide 5 Albumin-Bound Paclitaxel 5 Sorafenib 4 Radiation 4 Nivolumab 4 Ipilimumab 4 vosaroxin 3 Radiotherapy, Intensity-Modulated 3 Octreotide 3 Irinotecan 3 Bevacizumab 3 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 3 pralsetinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡